ENB Therapeutics Presents Top-line Results from Phase 1b ENBOLDEN-101 Study in Solid Tumors Refractory to Standard of Care at the Immuno-oncology Summit 2023 ...

Cite this: New Options for Refractory Gout Are Showing Promise in Late-Phase Trials - Medscape - July 09, 2024. Comments Commenting is limited to medical professionals.

Mezigdomide combined with other standard therapies in relapsed or refractory myeloma has yielded promising results thus far in a phase 1–2 study (ClinicalTrials.gov number, NCT03989414), 39 and ...

Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Patients With Relapsed and/or Refractory Multiple Myeloma (RRMM) (abstract #4825) In the Phase 1 study, 40 patients were enrolled ...

Genentech’s Phase III STARGLO Study Demonstrates Columvi Significantly Extends Survival in People With Relapsed or Refractory Diffuse Large B-cell Lymphoma Published Jun 15, 2024 10:00am EDT ...

Moleculin Biotech, Inc. has commenced enrollment and dosing in its Phase 3 clinical trial, MIRACLE, which evaluates Annamycin (naxtarubicin) for treating relapsed or refractory acute myeloid ...

Primary overall survival analysis of the phase 3 randomized ZUMA-7 study of axicabtagene ciloleucel versus standard-of-care therapy in relapsed/refractory large B-cell lymphoma. Authors : Jason Westin ...

Cellectar Biosciences Provides Update on CLOVER-2 Phase 1 Clinical Trial of Iopofosine I 131 in Pediatric Patients with Relapsed/Refractory High-Grade Glioma Provided by GlobeNewswire Jun 11, 2025 ...

Currently in the Phase 1 trial for refractory lupus nephritis (LN, lupus-related kidney disease in which people do not respond to first-line immunosuppressive drugs or quickly relapse after remission) ...

Medivation announces it's MDV3100 demonstrates "substantial" PSA reductions in first patient groups treated in Phase 1-2 hormone refractory prostate cancer trial By Reuters November 5, 2007 12:22 ...